RANK-RANKL signalling in cancer: RANK-RANKL and cancer

Abstract : Oncogenic events combined with a favourable environment are the two main factors in the oncological process. The tumour microenvironment is composed of a complex, interconnected network of protagonists, including soluble factors such as cytokines, extracellular matrix components, interacting with fibroblasts, endothelial cells, immune cells and various specific cell types depending on the location of the cancer cells (e.g. pulmonary epithelium, osteoblasts). This diversity defines specific "niches" (e.g. vascular, immune, bone niches) involved in tumour growth and the metastatic process. These actors communicate together by direct intercellular communications and/or in an autocrine/paracrine/endocrine manner involving cytokines and growth factors. Among these glycoproteins, RANKL (receptor activator nuclear factor-κB ligand) and its receptor RANK (receptor activator nuclear factor), members of the TNF and TNFR superfamilies, have stimulated the interest of the scientific community. RANK is frequently expressed by cancer cells in contrast with RANKL which is frequently detected in the tumour microenvironment and together they participate in every step in cancer development. Their activities are markedly regulated by osteoprotegerin (OPG, a soluble decoy receptor) and its ligands, and by LGR4, a membrane receptor able to bind RANKL. The aim of the present review is to provide an overview of the functional implication of the RANK/RANKL system in cancer development, and to underline the most recent clinical studies.
Type de document :
Article dans une revue
Bioscience Reports, Portland Press, 2016, 36 (4), pp.e00366 - e00366. 〈10.1042/BSR20160150〉
Liste complète des métadonnées

Littérature citée [74 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01644732
Contributeur : Dominique Heymann <>
Soumis le : mercredi 22 novembre 2017 - 15:19:23
Dernière modification le : jeudi 5 avril 2018 - 10:36:48

Fichier

Renema et al_e00366.full.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Nathalie Renema, Benjamin Navet, Marie-Françoise Heymann, Frédéric Lézot, Dominique Heymann. RANK-RANKL signalling in cancer: RANK-RANKL and cancer. Bioscience Reports, Portland Press, 2016, 36 (4), pp.e00366 - e00366. 〈10.1042/BSR20160150〉. 〈inserm-01644732〉

Partager

Métriques

Consultations de la notice

54

Téléchargements de fichiers

58